Charité as Venue: A Signal for Scientific Anchoring
The choice of venue is far more than a logistical decision. With CVK Forum 3 on the Virchow-Klinikum Campus, the congress establishes itself in the heart of one of Europe’s most prestigious university hospitals. This location shifts the perception of cannabis medicine in Germany further away from niche topic status and toward academic healthcare research. For participating pharmacists, physicians, and industry representatives, it means operating within an environment shaped by clinical routine.
📑 Inhaltsverzeichnis
Accreditation with twelve CME continuing education credits underscores this ambition. This formally places the MCC within standard medical education formats. Physicians attending fulfill their continuing education obligations directly without detouring through additional events.
Program and Speakers: Focus on Pain and Mental Health
The speaker roster includes Dr. Konrad F. Cimander, director of the Cannabis Medicine Competence Center in Hannover, and Dr. Christiane Neubaur, CEO of the VCA. With Dr. med. Richard Ibrahim, president of the German Society for Pain Medicine (DGS), there is representation from someone who understands the tension between classical pain therapy and cannabinoid-based treatment. This aligns with the chosen theme: resilience and mental stability are topics that centrally concern both pain medicine and psychiatric care with cannabinoids.
The program is structured into lectures, workshops, and poster presentations. A separate Industry Lounge offers space for manufacturers to present research findings and products. Unlike pure business events, the scientific core remains primary, with industry engagement clearly separated spatially and programmatically.
Clear Ticket Structure: Two Days at a Flat Rate
While the parallel Cannabis business summits in Frankfurt and London in May 2026 charge high three- to four-digit entry fees, the Medicinal Cannabis Congress asks 250 euros for a two-day ticket. Day tickets are deliberately not offered—the organizers emphasize continuous participation across both congress days. Press representatives receive free access. This structure targets supply-side practitioners: pharmacists, physicians, and independent therapists receive a calculable, uniform conference rate without tiered pricing.
With this approach, the MCC positions itself as a deliberate counterweight to investor-focused formats. Scientific sponsorship through DMCG e.V. and DGS ensures the clinical-scientific focus, while K.I.T. Group GmbH handles organizational implementation. Those seeking an event between major industry meetings that specifically addresses prescribing practice, pharmacy supply, and clinical research will find a clear profile here. May 2026 is densely scheduled for Germany’s cannabis sector: first the World Class Cannabis Business Europe in Frankfurt, then Cannabis Europa in London, and finally the MCC in Berlin.
Supply Questions Mounting: Why the MCC 2026 Is Politically Relevant
The timing coincides with a phase when German medicinal cannabis supply faces multiple changes. The federal government plans a shipping ban for cannabis flower, tighter binding of prescriptions to direct physician-patient contact, and stricter requirements for telemedicine. Simultaneously, the question arises whether statutory health insurance will discontinue reimbursement of cannabis flower permanently. These are immediate practice issues for pharmacists and treating physicians, not merely political background noise.
The VCA as supporting organization has repeatedly commented on these reform plans in recent months and called for improvements to the Medicinal Cannabis Act. At the congress, therefore, not only clinical evidence should dominate but also professional-political exchange about upcoming regulatory steps. Reviewing the program reveals a conference embedding its speakers in German supply-side reality.
Frequently Asked Questions
When and where does the Medicinal Cannabis Congress 2026 take place?
The seventh Medicinal Cannabis Congress runs May 28-29, 2026 at CVK Forum 3 on the Virchow-Klinikum Campus at Charité Berlin. The organizer is K.I.T. Group GmbH; scientific sponsors are the German Medicinal Cannabis Society (DMCG e.V.) and the German Society for Pain Medicine (DGS). The conference is supported by the Association of Cannabis-Supplying Pharmacies (VCA).
Who is the target audience?
The congress targets physicians, pharmacists, and industry representatives working in medicinal cannabis supply. The continuous two-day structure and CME-accredited program demonstrate that the event deliberately addresses operational supply-side practice rather than primarily investors or wholesalers.
How many CME credits are available?
The conference is recognized with twelve CME continuing education credits. This allows physician participants to formally count attendance toward their mandatory continuing education requirements.
What does a ticket cost?
Only a two-day ticket at 250 euros is available—day tickets are not offered by the organizer. Press representatives attend free of charge. Current booking options and terms are found at medicinal-cannabis-congress.org.
What is the theme of MCC 2026?
Under the keynote theme „Resilience and Mental Stability—A Holistic Approach,“ lectures and workshops address the intersection of cannabis therapy, pain medicine, and mental health. The speaker roster featuring representatives from DGS and cannabis competence centers reflects this interdisciplinary ambition.
How does the MCC differentiate from other cannabis conferences in 2026?
In May 2026, three major industry events occur simultaneously: World Class Cannabis Business Europe in Frankfurt, Cannabis Europa in London, and the MCC. Unlike the business summits, the Berlin congress focuses on supply-side practice and clinical content. Industry representatives are present in a separate Industry Lounge, while the main program remains scientific-medical in character.
Würdest du als Patient einen Cannabismedizin-Kongress besuchen?
Sources: Medicinal Cannabis Congress (medicinal-cannabis-congress.org), K.I.T. Group GmbH (organizer, correction notice May 8, 2026), DMCG – German Medicinal Cannabis Society e.V. (medi-can.de), DGS – German Society for Pain Medicine, VCA – Association of Cannabis-Supplying Pharmacies e.V. (vca-deutschland.de), Charité – University Medicine Berlin (as of May 8, 2026).
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
